1. Home
  2. BSX vs JCI Comparison

BSX vs JCI Comparison

Compare BSX & JCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$53.95

Market Cap

93.4B

Sector

Health Care

ML Signal

HOLD

Logo Johnson Controls International plc

JCI

Johnson Controls International plc

HOLD

Current Price

$139.66

Market Cap

83.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSX
JCI
Founded
1979
1885
Country
United States
Ireland
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
93.4B
83.5B
IPO Year
2010
2007

Fundamental Metrics

Financial Performance
Metric
BSX
JCI
Price
$53.95
$139.66
Analyst Decision
Strong Buy
Buy
Analyst Count
22
16
Target Price
$93.18
$134.60
AVG Volume (30 Days)
16.2M
2.9M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
N/A
1.13%
EPS Growth
55.20
99.60
EPS
0.90
1.86
Revenue
$9,076,000,000.00
$9,902,000,000.00
Revenue This Year
$11.85
$7.61
Revenue Next Year
$10.16
$6.57
P/E Ratio
$63.11
$75.21
Revenue Growth
12.49
N/A
52 Week Low
$54.98
$96.01
52 Week High
$109.50
$147.32

Technical Indicators

Market Signals
Indicator
BSX
JCI
Relative Strength Index (RSI) 29.22 48.16
Support Level N/A $135.10
Resistance Level $76.77 $144.82
Average True Range (ATR) 2.04 3.43
MACD -0.28 -0.51
Stochastic Oscillator 1.01 22.08

Price Performance

Historical Comparison
BSX
JCI

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

About JCI Johnson Controls International plc

Following Johnson Controls' divestiture of its residential and light commercial HVAC businesses to Bosch in 2025, nearly all of its revenue comes from commercial HVAC (60%) and fire and security products and services (40%). A 2016 merger joined Johnson Controls' HVAC and Tyco's fire and security businesses with the premise that there is synergy in offering a broader variety of automation products and solutions to commercial buildings. We estimate Johnson Controls' pro forma revenue mix will be one-third products, one-third installation, and one-third services.

Share on Social Networks: